Goldman Sachs Group Inc Cbd Md, Inc. Transaction History

Goldman Sachs Group Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 14, 2024	BUY	$0.16 - $0.34 $4 - $9	27 Added 0.07%	37,123 $7,000
Q1 2023 May 11, 2023	BUY	$0.16 - $0.34 $4 - $9	27 Added 0.07%	37,123 $7,000
Q4 2022 May 14, 2024	BUY	$0.22 - $15.3 $6 - $474	31 Added 0.08%	37,096 $8,000
Q4 2022 Feb 13, 2023	BUY	$0.22 - $15.3 $6 - $474	31 Added 0.08%	37,096 $8,000
Q3 2022 May 14, 2024	SELL	$0.0 - $21.78 $0 - $805	-37 Reduced 0.1%	37,065 $9,000
Q3 2022 Nov 10, 2022	SELL	$0.0 - $21.78 $0 - $805	-37 Reduced 0.1%	37,065 $0
Q2 2022 May 14, 2024	BUY	$0.0 - $0.0 $0 - $0	37,102 New	37,102 $16,000
Q2 2022 Aug 15, 2022	BUY	$0.0 - $0.0 $0 - $0	37 Added 0.1%	37,102 $16,000
Q1 2022 May 16, 2022	SELL	$0.0 - $0.0 $0 - $0	-282 Reduced 0.76%	37,065 $39,000
Q4 2021 Feb 14, 2022	SELL	$0.0 - $6.95 $0 - $34	-5 Reduced 0.01%	37,347 $40,000
Q3 2021 Nov 10, 2021	BUY	$0.0 - $7.49 $0 - $279,766	37,352 New	37,352 $77,000

125K

Ticker YCBD
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,555,600
Market Cap $29.1M
Description
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.